Novartis announced a partnership with Salesforce’s Agentforce Life Sciences platform to connect patient and healthcare professional experiences, enabling its teams to focus on strategic and meaningful customer interactions. The collaboration will deploy Agentforce’s AI‑driven engagement tools across Novartis’s global sales and support functions, with the goal of personalizing communication and improving care coordination. The partnership does not involve a large capital outlay, underscoring Novartis’s commitment to leveraging technology for patient outcomes and operational efficiency.
The deal is part of a five‑year rollout plan for Agentforce 360 for Life Sciences. Novartis has already invested in other Salesforce products—including Agentforce Health, Data 360 for Health & Life Sciences, MuleSoft for Life Sciences, and Agentforce Marketing—demonstrating a deepening relationship with the platform ecosystem.
Agentforce Life Sciences uses AI agents to automate routine tasks, provide real‑time insights, and personalize communications with patients, prescribers, and payers. The platform also harmonizes data across disparate sources to give a unified view of the customer journey, enabling more accurate and connected experiences.
The new platform will be rolled out across sales, marketing, medical affairs, and patient services, allowing teams to focus on high‑value interactions while reducing administrative burden. The partnership is expected to improve care coordination and data insights that inform product positioning and market strategy.
The collaboration signals Novartis’s continued commitment to its digital transformation agenda, which aims to improve patient outcomes and operational efficiency. By expanding its Salesforce ecosystem, Novartis positions itself to compete more effectively in a digital‑first healthcare landscape.
Frank Defesche, General Manager of Life Sciences at Salesforce, said the expanded partnership underscores the company’s commitment to transforming how the life sciences industry engages with marketing, sales, and medical stakeholders, providing a foundation for more personal, accurate, and connected experiences.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.